<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36944412</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN><JournalIssue CitedMedium="Internet"><Volume>329</Volume><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Virus research</Title><ISOAbbreviation>Virus Res</ISOAbbreviation></Journal><ArticleTitle>Inhibitory effects and mechanisms of proanthocyanidins against enterovirus 71 infection.</ArticleTitle><Pagination><StartPage>199098</StartPage><MedlinePgn>199098</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">199098</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2023.199098</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-1702(23)00060-6</ELocationID><Abstract><AbstractText>Proanthocyanidins (PC), a natural flavonoid compound, was reported to possess a variety of pharmacological activities such as anti-tumor and anti-viral effects. In this study, the anti-Enterovirus 71 (EV71) activities and mechanisms of PC were investigated both in vitro and in vivo. The results showed that PC possessed anti-EV71 activities in different cell lines with low toxicity. PC can block both the adsorption and entry processes of EV71 via directly binding to virus VP1 protein. PC may competitively interfere with the binding of VP1 to its receptor SCARB2. PC can also regulate three different MAPK signaling pathways to reduce EV71 infection and attenuate virus induced inflammatory responses. Importantly, intramuscular therapy of EV71-infected mice with PC markedly improved their survival and attenuated the severe clinical symptoms. Therefore, the natural compound PC has potential to be developed into a novel anti-EV71 agent targeting viral VP1 protein and MAPK pathways.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jiqin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education; School of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao, 266003, P. R. China; Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao, 266237, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xiaoyao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education; School of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao, 266003, P. R. China; Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao, 266237, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Lishan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education; School of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao, 266003, P. R. China; Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao, 266237, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education; School of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao, 266003, P. R. China; Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao, 266237, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Cui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Research Center, the Affiliated Hospital of Qingdao University, Qingdao, 266003, P. R. China. Electronic address: haocui@qduhospital.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Key Laboratory of Marine Drugs, Chinese Ministry of Education; School of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao, 266003, P. R. China; Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao, 266237, P. R. China. Electronic address: wwwakin@ouc.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virus Res</MedlineTA><NlmUniqueID>8410979</NlmUniqueID><ISSNLinking>0168-1702</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044945">Proanthocyanidins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044945" MajorTopicYN="Y">Proanthocyanidins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">MAPK pathway</Keyword><Keyword MajorTopicYN="N">Proanthocyanidins</Keyword><Keyword MajorTopicYN="N">VP1 protein</Keyword><Keyword MajorTopicYN="N">Virus entry</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36944412</ArticleId><ArticleId IdType="pmc">PMC10194253</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2023.199098</ArticleId><ArticleId IdType="pii">S0168-1702(23)00060-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aswathyraj S., Arunkumar G., Alidjinou E.K., Hober D. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med. Microbiol. Immunol. 2016;205(5):397&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Wang W., Yu S., Wang H., Tian Z., Zhu S. Procyanidins and their therapeutic potential against oral diseases. Molecules. 2022;27(9):2932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9104295</ArticleId><ArticleId IdType="pubmed">35566283</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J., Wang G., Li W., Zhang L., Yang J., Zhao X., Chen X., Xu Y., Li K. High-throughput screening for anti-influenza A virus drugs and study of the mechanism of procyanidin on influenza A virus-induced autophagy. J. Biomol. Screen. 2012;17(5):605&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pubmed">22286278</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W., Wu Y., Bi J., Wang S., Li F., Kong W., Barbier J., Cintrat J.C., Gao F., Gillet D., Su W., Jiang C. Antiviral effects of ABMA against herpes simplex virus type 2 in vitro and in vivo. Viruses. 2018;10(3):119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869512</ArticleId><ArticleId IdType="pubmed">29522484</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M., Wang X., Wang Q., Wang Y., Lin J., Sun Y., Li X., Zhang L., Lou Z., Wang J., Rao Z. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell. 2014;5(9):692&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauvelle C., Lambotin M., Heydmann L., Prakash E., Bhaskaran S., Vishwaraman M., Baumert T.F., Moog C. A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entry. Hepatol. Int. 2017;11(5):440&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pubmed">28698985</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Cardoso K., Comitato R., Gines I., Ardevol A., Pinent M., Virgili F., Terra X., Blay M. Protective effect of proanthocyanidins in a rat model of mild intestinal inflammation and impaired intestinal permeability induced by LPS. Mol. Nutr. Food Res. 2019;63(8)</Citation><ArticleIdList><ArticleId IdType="pubmed">30656830</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Zhang R., Wu W., Duan G. Antiviral and inflammatory cellular signaling associated with enterovirus 71 infection. Viruses. 2018;10(4):155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5923449</ArticleId><ArticleId IdType="pubmed">29597291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z., Ye X., Shi J., Wang X., Liu Q., Huang Z. Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J. Virol. 2015;89(23):12084&#x2013;12095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4645313</ArticleId><ArticleId IdType="pubmed">26401034</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Lin A., Yu C., Zhang Z., Xu D., Hu W., Liu L., Wang S., Nie X., Sun W., Gai Z., Chen Z. Association of enterovirus 71 encephalitis with the interleukin-8 gene region in Chinese children. Infect. Dis. (Lond.) 2015;47(6):418&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pubmed">25751776</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Xu C., Hao C., Zhang Y., Wang Z., Wang S., Wang W. Inhibition of herpes simplex virus by myricetin through targeting viral gD protein and cellular EGFR/PI3K/Akt pathway. Antiviral Res. 2020;177</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7111628</ArticleId><ArticleId IdType="pubmed">32165083</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y.W., Ho B.C., Chen M.H., Yu S.L. Host relieves lnc-IRAK3-3-sequestered miR-891b to attenuate apoptosis in enterovirus 71 infection. Cell. Microbiol. 2019;21(9):e13043.</Citation><ArticleIdList><ArticleId IdType="pubmed">31099182</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W.Y., Yu Y.J., Jinn T.R. Evaluation of the virucidal effects of rosmarinic acid against enterovirus 71 infection via in vitro and in vivo study. Virol. J. 2019;16(1):94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6670152</ArticleId><ArticleId IdType="pubmed">31366366</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Yin W., Wang J., Lei Y., Sun G., Li W., Huang Z., Guo M. KRAB-zinc finger protein ZNF268a deficiency attenuates the virus-induced pro-inflammatory response by preventing IKK complex assembly. Cells. 2019;8(12):1604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6953056</ArticleId><ArticleId IdType="pubmed">31835635</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Gao Z., Liu C., Long M., Yang L., Li R., Dong K., Zhang H. Integrative analysis of lncRNA-miRNA-mRNA-associated competing endogenous RNA regulatory network involved in EV71 infection. Am. J. Transl. Res. 2021;13(7):7440&#x2013;7457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340214</ArticleId><ArticleId IdType="pubmed">34377228</ArticleId></ArticleIdList></Reference><Reference><Citation>Maroli N., Bhasuran B., Natarajan J., Kolandaivel P. The potential role of procyanidin as a therapeutic agent against SARS-CoV-2: a text mining, molecular docking and molecular dynamics simulation approach. J. Biomol. Struct. Dyn. 2022;40(3):1230&#x2013;1245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7544928</ArticleId><ArticleId IdType="pubmed">32960159</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H., Shi M., Zhang L., Li Y., Sun J., Zhang L., Wang X., Xu X., Zhang X., Mao Y., Ji Y., Jiang J., Shi W. Activation of JNK1/2 and p38 MAPK signaling pathways promotes enterovirus 71 infection in immature dendritic cells. BMC Microbiol. 2014;14:147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057572</ArticleId><ArticleId IdType="pubmed">24906853</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn R.J., Rossmann M.G. Crystal structure of human enterovirus 71. Science. 2012;336(6086):1274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M., Khanbabaei H., Teimoori A. An update on enterovirus 71 infection and interferon type I response. Rev. Med. Virol. 2019;29(1):e2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169063</ArticleId><ArticleId IdType="pubmed">30378208</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauf A., Imran M., Abu-Izneid T., Iahtisham Ul H., Patel S., Pan X., Naz S., Sanches Silva A., Saeed F., Rasul Suleria H.A. Proanthocyanidins: a comprehensive review. Biomed. Pharmacother. 2019;116</Citation><ArticleIdList><ArticleId IdType="pubmed">31146109</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Y., Jin Q., Zeng J., Ren F., Xie Z., Ji K., Wu L., Wu J., Li L. Grape seed proanthocyanidin extract ameliorates cardiac remodelling after myocardial infarction through PI3K/AKT pathway in mice. Front. Pharmacol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7747856</ArticleId><ArticleId IdType="pubmed">33343353</ArticleId></ArticleIdList></Reference><Reference><Citation>Smither S.J., Lear-Rooney C., Biggins J., Pettitt J., Lever M.S., Olinger G.G., Jr. Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. J. Virol. Method. 2013;193(2):565&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">23748121</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain S.K., Gadnayak A., Mohanty J.N., Sarangi R., Das J. Does enterovirus 71 urge for effective vaccine control strategies? Challenges and current opinion. Rev. Med. Virol. 2022;32(4):e2322.</Citation><ArticleIdList><ArticleId IdType="pubmed">34997684</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Dai Y., Cheng J., Sun C., Chen Y., Cui D. Analysis of the complete genomes of enterovirus 71 subtypes in China. Can. J. Infect. Dis. Med. Microbiol. 2021;2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416384</ArticleId><ArticleId IdType="pubmed">34484496</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Yin R., Zhang M., Yu R., Hao C., Zhang L., Jiang T. Boronic acid modifications enhance the anti-influenza a virus activities of novel quindoline derivatives. J. Med. Chem. 2017;60(7):2840&#x2013;2852.</Citation><ArticleIdList><ArticleId IdType="pubmed">28267329</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao C., Hu K., Xi C., Li N., Wei Y. Transcriptomic analysis of cells in response to EV71 infection and 2A(pro) as a trigger for apoptosis via TXNIP gene. Genes Genom. 2019;41(3):343&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">30499052</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.X., Huang Y.M., Li Q.J., Li X.Y., Zhou Y.D., Guo F., Zhou J.M., Cen S. A highly conserved amino acid in VP1 regulates maturation of enterovirus 71. PLoS Pathog. 2017;13(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5634653</ArticleId><ArticleId IdType="pubmed">28938017</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Dong Z., Wei Q., Carr M.J., Li J., Ding S., Tong Y., Li D., Shi W. A neonatal murine model of coxsackievirus A6 infection for evaluation of antiviral and vaccine efficacy. J. Virol. 2017;91(9) e02450&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5391469</ArticleId><ArticleId IdType="pubmed">28250116</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Zhang L., Yang C., Li Z., Rong S. Procyanidins and Alzheimer's disease. Mol. Neurobiol. 2019;56(8):5556&#x2013;5567.</Citation><ArticleIdList><ArticleId IdType="pubmed">30649713</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Zhao Y., Kotecha A., Fry E.E., Kelly J.T., Wang X., Rao Z., Rowlands D.J., Ren J., Stuart D.I. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat. Microbiol. 2019;4(3):414&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>